| Literature DB >> 33987097 |
Xianning Wu1, Tian Li1, Chuankai Zhang1, Gao Wu1, Ran Xiong1, Meiqing Xu1, Dan Su2, Mingran Xie1.
Abstract
INTRODUCTION: Segmentectomy is widely used for early-stage lung cancer presenting as single or multiple ground-glass opacities (GGOs). Precise segmentectomy is the recommended procedure in China. However, clinically, most routine segmentectomies are performed using only high-resolution computed tomography (CT). The aim of this study was to evaluate the effect of two segmentectomy approaches for GGOs in the lung.Entities:
Keywords: early-stage lung cancer; ground-glass opacities; propensity score; segmentectomy; video-assisted thoracoscopy
Year: 2021 PMID: 33987097 PMCID: PMC8111074 DOI: 10.3389/fonc.2021.661821
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1The flow chart of patient selection.
Figure 2Routine left S10 segmentectomy based on CT scan and normal anatomic characteristics. (A) CT scan showed a GGOs lesion in the left S10; (B) The branches of the pulmonary artery exposed in the VATS were consistent with CT. (C, D) Surgical details were compared with segmental atlas written by Hiroaki Nomori and Morihito Okada. CT, computed tomography; VATS, video-assisted thoracoscopy; GGOs, ground-glass opacities.
Figure 3Precise left S10 segmentectomy according to the real-time 3D reconstruction guidance. (A) CT scan showed a GGOs lesion in the left S10; Branches pulmonary vein (B), bronchus (C), and pulmonary artery (D) of the target segment were confirmed by real-time guidance of 3D reconstruction. 3D, three-dimensional.
Demographic data of precise and routine VATS uniportal segmentectomy.
| Variables* | Before matching | After matching | |||||
|---|---|---|---|---|---|---|---|
| All | Precision | Routine |
| Precision | Routine |
| |
| (N = 353) | (N = 55) | (N = 298) | (N = 55) | (N = 55) | |||
| Age(years) | 50.5 ± 5.3 | 52.9 ± 10.4 | 47.6 ± 12.6 | 0.108 | 52.9 ± 10.4 | 53.1 ± 11.9 | 0.978 |
| Gender | |||||||
| Male | 162 (45.9) | 20 (36.4) | 142 (47.7) | 0.142 | 20 (36.4) | 23 (41.8) | 0.696 |
| Female | 191 (54.1) | 35 (63.6) | 156 (52.3) | 35 (63.6) | 32 (58.2) | ||
| BMI | 23.6 ± 3.2 | 23.9 ± 3.6 | 23.5 ± 2.7 | 0.342 | 23.9 ± 3.6 | 23.8 ± 3.0 | 0.898 |
| Surgery Type | |||||||
| Simple | 164 (46.5) | 19 (34.5) | 145 (48.7) | 0.057 | 19 (34.5) | 19 (34.5) | 1.000 |
| Complex | 189 (53.5) | 36 (65.5) | 153 (51.3) | 36 (65.5) | 36 (65.5) | ||
| Pre-op FEV1(L) | 2.36 ± 0.42 | 2.38 ± 0.61 | 2.30 ± 0.38 | 0.406 | 2.38 ± 0.61 | 2.37 ± 0.74 | 0.933 |
*Variables used for estimating propensity score. BMI, body mass index; FEV1, forced expiratory volume in 1 s; VATS, video-assisted thoracoscopic surgery.
Types of VATS segmentectomy in Precision group and Routine group.
| Surgery types | Precision group | Routine group |
|---|---|---|
| Rright upper lobe | 12 (21.8%) | 13 (23.6%) |
| S1 | 2 | 2 |
| S2 | 2 | 2 |
| S3 | 3 | 3 |
| S2b + 3a | 5 | 6 |
| Right lower lobe | 14 (25.5%) | 13 (23.6%) |
| S6 | 3 | 3 |
| S8 | 3 | 3 |
| S9 | 2 | 2 |
| S10 | 5 | 5 |
| S9 + 10 | 1 | 0 |
| Left upper lobe | 16 (29.1%) | 16 (29.1%) |
| S1 + 2(a + b) | 7 | 6 |
| S1 + 2(c) | 1 | 2 |
| S1 + 2 | 3 | 3 |
| S3 | 2 | 3 |
| S1 + 2 + 3 | 1 | 1 |
| S4 + 5 | 2 | 1 |
| Left lower lobe | 13 (23.6%) | 13 (23.6%) |
| S6 | 2 | 2 |
| S8 | 1 | 1 |
| S9 | 3 | 2 |
| S10 | 6 | 7 |
| S9 + 10 | 1 | 1 |
Complex segmentectomy: Right S2b + 3a, S3; left S1 + 2(a + b), S3; and all S8, S9, S10 and S9 + 10.
Intraoperative and postoperative characters of Precision group and Routine group.
| Variables | Precision group (N = 55) | Routine group (N = 55) |
|
|---|---|---|---|
| Operation time (min) | 74 ± 14.6 | 55 ± 17.8 | <0.01 |
| Intraoperative blood loss (ml) | 33 ± 7.5 | 28 ± 9.0 | 0.215 |
| Inadequate resection margins | 0 | 4 (7.3%) | 0.118 |
| Number of removed lymph nodes | 5 ± 1.1 | 3 ± 0.8 | <0.01 |
| Histological type | 0.108 | ||
| Adenocarcinoma | 10 (18.2%) | 3 (5.5%) | |
| Microinvasive adenocarcinoma | 41 (74.5%) | 46 (83.6%) | |
| Invasive adenocarcinoma | 4 (7.3%) | 6 (10.9%) | |
| Chest tube duration days | 3.9 ± 1.7 | 3.7 ± 1.9 | 0.687 |
| Air leakage on POD1 | 31 (56.4%) | 19 (16.4%) | 0.020 |
| Postoperative hospital stay (days) | 4.4 ± 1.3 | 4.1 ± 2.2 | 0.619 |
| Postoperative complications | |||
| Air leakage (>7 days) | 2 (3.6%) | 3 (5.5%) | |
| Pneumonia | 0 | 1 (1.8%) | |
| Atrial fibrillation | 1 (1.8%) | 0 | |
| Hemoptysis (>10 ml) | 0 | 0 | |
| Total | 3 (5.5%) | 4 (7.3%) | 1.000 |
| Post-op FEV1 (L)* | 2.00 ± 0.53 | 1.89 ± 0.71 | 0.741 |
*Postoperative pulmonary functions were evaluated 1 month after surgery. POD, Postoperative Day. All patients’ air leakage on POD1 were under grade II.